Home » Topics » Regulatory

Regulatory
RSS

Mallinckrodt's MRI contrast agent approved for marketing in U.S.

Dec. 13, 1999

Dusa receives first approval of Levulan PDT for treatment of actinic keratoses

Dec. 10, 1999

Zoloft receives FDA approval for posttraumatic stress disorder

Dec. 10, 1999

Novartis reports setbacks and advances in the development of new chelating agents

Dec. 8, 1999

FDA advisory panel will review MS indication for Novantrone in early 2000

Dec. 8, 1999

Nasonex Nasal Spray approved for new pediatric indication in U.S.

Dec. 3, 1999

FDA approves new epilepsy treatment

Dec. 2, 1999

V1A/AT1 receptor antagonist combinations for cardiovascular disorders

Dec. 2, 1999

Combinations of imidazoles for female genital infections

Dec. 1, 1999

NMDA antagonists reported to be useful for IBS

Dec. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...